<DOC>
	<DOCNO>NCT01680107</DOCNO>
	<brief_summary>The purpose study determine whether d-cycloserine augments clinical effect exposure-based cognitive-behaviour therapy panic disorder .</brief_summary>
	<brief_title>D-cycloserine Augmented CBT Panic Disorder</brief_title>
	<detailed_description />
	<mesh_term>Disease</mesh_term>
	<mesh_term>Panic Disorder</mesh_term>
	<mesh_term>Cycloserine</mesh_term>
	<criteria>clinical diagnosis panic disorder least moderate agoraphobic avoidance psychoactive medication last 6 week exposurebased cognitivebehaviour treatment panic disorder agoraphobia last 3 month female participant pregnant breastfeeding lifetime history psychosis , bipolar disorder , alcohol , medication drug abuse dependence ; current primary depressive disorder lifetime history epilepsy significant disease disorder</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>65 Years</maximum_age>
	<verification_date>November 2015</verification_date>
	<keyword>d-cycloserine , cognitive-behaviour therapy , panic disorder</keyword>
</DOC>